安裝 Steam
登入
|
語言
簡體中文
日本語(日文)
한국어(韓文)
ไทย(泰文)
Български(保加利亞文)
Čeština(捷克文)
Dansk(丹麥文)
Deutsch(德文)
English(英文)
Español - España(西班牙文 - 西班牙)
Español - Latinoamérica(西班牙文 - 拉丁美洲)
Ελληνικά(希臘文)
Français(法文)
Italiano(義大利文)
Bahasa Indonesia(印尼語)
Magyar(匈牙利文)
Nederlands(荷蘭文)
Norsk(挪威文)
Polski(波蘭文)
Português(葡萄牙文 - 葡萄牙)
Português - Brasil(葡萄牙文 - 巴西)
Română(羅馬尼亞文)
Русский(俄文)
Suomi(芬蘭文)
Svenska(瑞典文)
Türkçe(土耳其文)
tiếng Việt(越南文)
Українська(烏克蘭文)
回報翻譯問題
The impetus for this decision was reports from Scandinavia of 30 serious blood clot events following the administering of five million doses of the vaccine in question which is manufactured by AstraZeneca, the British-Swedish multinational pharmaceutical company.
So is the vaccine safe? To answer that, we can look at the data from trials conducted on the vaccine before it was approved by the European Medicines Agency and other regulators. They showed an excellent safety profile and no evidence of induced blood clotting. And despite the current concerns, emerging data does not conclusively suggest any increase in clotting risk either.
-"Studley Mancannon" c.2021 17/03